A Multi-Center Phase 1 Study of the Safety and Tolerability of Dimebon in Alzheimer's Disease Patients on Memantine (Cohort 1) and Memantine Plus Donepezil (Cohort 2).

Trial Profile

A Multi-Center Phase 1 Study of the Safety and Tolerability of Dimebon in Alzheimer's Disease Patients on Memantine (Cohort 1) and Memantine Plus Donepezil (Cohort 2).

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Nov 2015

At a glance

  • Drugs Donepezil; Latrepirdine; Memantine
  • Indications Alzheimer's disease
  • Focus Adverse reactions
  • Sponsors Medivation
  • Most Recent Events

    • 10 Apr 2010 Status changed from active, no longer recruiting to completed as per results reported at 62nd Annual Meeting of the American Academy of Neurology.
    • 10 Apr 2010 Results presented at 62nd Annual Meeting of the American Academy of Neurology.
    • 16 Apr 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top